Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research Article

TGF-α, c-erbB-2 Expression and Neoangiogenesis in Vulvar Squamous Cell Carcinoma

PEER HANTSCHMANN, UDO JESCHKE and KLAUS FRIESE
Anticancer Research May 2005, 25 (3A) 1731-1737;
PEER HANTSCHMANN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
UDO JESCHKE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KLAUS FRIESE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: TGFα and c-erbB-2 are important mediators of tumor neoangiogenesis linked to the epidermal growth factor receptor. Thus, we analyzed TGFα c-erbB-2 and tumor neoangiogenesis in vulvar carcinoma and determined their prognostic significance. Patients and Methods: Seventy-five carcinomas were evaluated for histological parameters. Tumors were stained immunohistologically for TGFα, c-erbB-2 and factor VIII antigen. Results were analyzed statistically by Ã2-test, Kaplan-Meier survival curves and log-rank-test. Results: Sixty-five % of the carcinomas were positive for TGFα in >50% of the tumor cells. C-erbB-2 overexpression occurred in 47% of the tumors, but there was frequently a high cytoplasmatic staining. Twenty-nine % showed high microvessel densitiy. These tumors were more likely to have vascular space involvement (p=0.02). In carcinomas with TGFα expression in >50% of the tumor cells, microvessel density was increased (p=0.05). Overall and disease-free survival tended to be reduced for tumors with high TGFα expression and microvessel density, but differences were not significant. Conclusion: Tumor neoangiogenesis is an important event in vulvar carcinogenesis which is related to the expression of growth factors.

  • Vulvar carcinoma
  • TGF-α
  • c-erbB-2
  • neoangiogenesis
  • immunohistology
  • prognosis
  • Received August 2, 2004.
  • Accepted February 8, 2005.
  • Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 25, Issue 3A
1 May 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
TGF-α, c-erbB-2 Expression and Neoangiogenesis in Vulvar Squamous Cell Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
TGF-α, c-erbB-2 Expression and Neoangiogenesis in Vulvar Squamous Cell Carcinoma
PEER HANTSCHMANN, UDO JESCHKE, KLAUS FRIESE
Anticancer Research May 2005, 25 (3A) 1731-1737;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
TGF-α, c-erbB-2 Expression and Neoangiogenesis in Vulvar Squamous Cell Carcinoma
PEER HANTSCHMANN, UDO JESCHKE, KLAUS FRIESE
Anticancer Research May 2005, 25 (3A) 1731-1737;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Tumor Proteomics by Multivariate Analysis on Individual Pathway Data for Characterization of Vulvar Cancer Phenotypes
  • A review of molecular pathological markers in vulvar carcinoma: lack of application in clinical practice
  • Google Scholar
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire